New Stock News | Dyna Technology submitted documents to the Hong Kong Stock Exchange and ranked second in the Chinese smart laboratory solutions market.

According to the disclosure from the Hong Kong Stock Exchange on April 28, Beijing Daina Experimental Technology Co., Ltd. (referred to as Daina Technology) has submitted its listing application to the Main Board of the Hong Kong Stock Exchange, with CICC and Sinolink (Hong Kong) as its joint sponsors. Company Overview According to the prospectus, the company is a leading provider of end-to-end solutions for smart laboratories in China. According to a report by Frost & Sullivan, based on revenue projections for 2025, the company ranks second in the Chinese smart laboratory solutions market and first among suppliers headquartered in China. According to the same source, the company ranks first in the field of "dark laboratory" solutions in China (the most advanced form of smart laboratory), with a market share of approximately 34.2% in the same year. With independently developed multimodal intelligent technology, industry-specific AI model platforms, and integrated capabilities, the company provides AI-driven R&D, quality control, and quality optimization one-stop services for fields such as chemicals, new materials, new energy, and life sciences. The company's end-to-end solutions include laboratory planning, intelligent module manufacturing, algorithm and automation integration, and intelligent operations, all supported by a design-manufacture-deploy-self-iterative integrated system driven by high-quality data. The company's solutions serve as the core infrastructure of the AIforScience paradigm, freeing researchers from repetitive manual labor to focus on more valuable discoveries and innovations, moving towards a self-sustaining and evolving dark laboratory. The urgent global need to accelerate scientific discovery is pushing the inherent limitations of manual experiments to a tipping point. Artificial intelligence models have an insatiable appetite for high-quality data, but this poses a sharp contradiction with the limited outputs and difficult-to-replicate results of human-led research, leading to a looming data scarcity crisis. Faced with these intertwined pressures and the grand mission of liberating scientific creativity and productivity from repetitive manual labor, the Chinese market for smart laboratory solutions is experiencing rapid expansion. Since its establishment, the company has focused on core areas such as smart laboratory equipment, intelligent system integration, and automated experimental processes. The company deeply integrates industry-specific AI models, Siasun Robot & Automation technology, and industry knowledge to drive scientific research and industrial quality control, breaking away from traditional reliance on manual labor to initiate a flywheel effect. The rapid progress of artificial intelligence in promoting dark laboratories for a wider range of applications generates a large amount of high-quality data, further optimizing artificial intelligence models and amplifying the demand for automated experiments. The company's clients mainly include enterprises in various industry verticals such as petrochemical and energy companies, biopharmaceutical companies and medical institutions, food companies, universities, research institutes, and industrial enterprises. In 2023, 2024, and 2025, the top five clients each contributed revenues of 58.0%, 67.8%, and 51.6% respectively, during the historical periods, while the largest client contributed revenues of 17.8%, 33.2%, and 16.0% respectively. Financial Information Revenue In 2023, 2024, and 2025, the company's revenue was approximately RMB 614 million, RMB 554 million, and RMB 645 million, respectively. Profit In 2023, 2024, and 2025, the company's annual profits were RMB 2.358 million, RMB 4.896 million, and RMB 16.397 million respectively. Gross Margin In 2023, 2024, and 2025, the company's gross margins were 16.1%, 23.6%, and 28.1%, respectively. Industry Overview The deep integration of artificial intelligence into scientific research (i.e., AIforScience (AI4S)) is becoming a core driver in reshaping the research paradigm. The State Council's opinion on deepening the implementation of the 'AI+ Action' clearly proposes to accelerate the exploration of an artificial intelligence-driven new research paradigm to speed up the process of basic and major scientific discoveries. According to the strategic goals set by this policy, it is expected that by 2027, the penetration rate of next-generation intelligent bodies and automated terminals will exceed 70%, and by 2030, it will exceed 90%, thereby empowering high-quality economic development in a comprehensive manner. This systemic reshaping of research productivity has gained broad consensus in the international academic community. The renowned academic journal Nature lists dark laboratories as one of the seven technologies worth watching in 2025, indicating that such automated research platforms will provide humans with affordable and scalable research capabilities. Driven by policy guidance and technological advancement, AI applications have evolved from a single tool to a systemic force reshaping the industrial ecosystem. Its widespread industrial deployment in complex settings such as manufacturing, healthcare, and transportation enhances AI's perception and execution capabilities, laying the foundation for deeper scientific applications. In recent years, the global market for smart laboratory solutions has maintained rapid growth, increasing from RMB 22.4 billion in 2021 to RMB 67 billion in 2025, with a compound annual growth rate of 31.5%. Looking ahead, with continued increase in downstream R&D investment and deep penetration of AI technology, the global market for smart laboratory solutions is expected to reach RMB 241.3 billion by 2030, with a compound annual growth rate of 29.2% from 2025 to 2030. The market for smart laboratory solutions in China has grown rapidly from RMB 2.5 billion in 2021 to RMB 10.7 billion in 2025, with a compound annual growth rate of 43.8%. By 2030, this market is expected to further increase to RMB 61.8 billion, with a compound annual growth rate of 42.1% from 2025 to 2030. In terms of application scenarios, life sciences and chemicals are currently the two main core application areas, accounting for over 60% of the overall market by 2025. Other sectors such as new energy, food, semiconductors, and environmental monitoring also show stronger growth momentum, with their market share expected to reach 17.2%, 9.8%, and 27.4% by 2030. The industrial application structure is gradually expanding from traditional laboratory-intensive areas to diverse emerging application scenarios. Board of Directors Information After compilation, the company's board of directors consists of eight directors, including five executive directors and three independent non-executive directors. The board of directors is responsible for the management and operation of the company and has full management authority. Directors serve a term of three years and are eligible for reappointment upon completion. Ownership Structure Mr. Chi, Mr. Zhang Huaidong, Ms. Jin Hui, Mr. Zhang Jingjun, Mr. Xing Xixue, Daina No. 1 Limited Partnership, Daina No. 2 Limited Partnership, Daina No. 3 Limited Partnership, and Beijing Juh are the controlling shareholders of the company until the final practical date (April 22, 2026) and will become the controlling shareholders of the company after compilation. Advisory Team Joint sponsors and compilers: CICC Financial Services Limited, Sinolink (Hong Kong) Limited; Legal advisers: Baker McKenzie LLP, Jingtian & Gongcheng Law Firm; Legal advisers to joint sponsors and compilers: JunHe LLP, JunHe LLP Beijing; Auditors and reporting accountants: KPMG LLP; Industry consultants: Frost & Sullivan (Beijing) Consulting Co., Ltd., Shanghai Branch.